Prospective Evaluation of Azacitidine Maintenance Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients with High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

被引：0
|
作者：
Gill, Harinder [1 ]
Lie, Albert Kwok Wai [1 ]
Kwong, Yok Lam [1 ]
Leung, Anskar Y. H. [1 ]
机构：
[1] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Azacitidine Maintenance Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Systematic Review
    Faisal, Muhammad Salman
    Hashim, Laila
    Samhouri, Yazan
    Abdullah, Syed Maaz
    Wahab, Ahsan
    Shahzad, Moazzam
    Ehsan, Hamid
    Ahmed, Zahoor
    Neupane, Karun
    Din, Asim Tameez Ud
    Anwer, Faiz
    Fazal, Salman
    BLOOD, 2020, 136
  • [2] Maintenance Therapy with Chidamide Plus Azacitidine after Allogeneic Hematopoietic Stem Cell Transplantation for High-Risk Acute Myeloid Leukemia Patients
    Hu, Xiaohui
    Wu, Depei
    Chen, Suning
    Wu, Yaxue
    Zhang, Yang
    Bai, Lian
    Wu, Bing
    Zhou, Haixia
    Xu, Mingzhu
    Jiang, Shanshan
    Qian, Chongsheng
    Xue, Shengli
    BLOOD, 2023, 142
  • [3] Prospective Phase II Study of Prophylactic Azacitidine and Donor Lymphocyte Infusions Following Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome
    Guillaume, Thierry
    Yakoub-Agha, Ibrahim
    Tabrizi, Reza
    Borel, Cecile
    Chevallier, Patrice
    Magro, Leonardo
    Vigouroux, Stephane
    Peterlin, Pierre
    Garnier, Alice
    Rubio, Marie-Therese
    Huynh, Anne
    Milpied, Noel
    Moreau, Philippe
    Mohty, Mohamad
    BLOOD, 2016, 128 (22)
  • [4] IMPACT OF AZACITIDINE PRETREATMENT ON OUTCOMES OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH HIGH-RISK MYELODYSPLASTIC SYNDROME
    Aoki, J.
    Konuma, T.
    Aoki, K.
    Iwato, K.
    Ozawa, Y.
    Kanda, Y.
    Ohashi, K.
    Uchida, N.
    Kobayashi, H.
    Sawa, M.
    Fukuda, T.
    Takanashi, M.
    Atsuta, Y.
    Ishiyama, K.
    HAEMATOLOGICA, 2017, 102 : 134 - 134
  • [5] Maintenance Azacitidine after Hematopoietic Stem Cell Transplantation for Relapse Prevention in Acute Myeloid Leukemia and Myelodysplastic Syndrome
    Americo, Andre Dias
    Kerbauy, Mariana Nassif
    da Silva, Cinthya Correa
    Chapchap, Eduardo Cerello
    Teixeira, Larissa
    de Souza dos Santos, Fabio Pirse
    Feitosa Ribeiro, Andreza Alice
    Hamerschlack, Nelson
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S206 - S206
  • [6] Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndrome
    Thierry Guillaume
    Florent Malard
    Leonardo Magro
    Myriam Labopin
    Reza Tabrizi
    Cécile Borel
    Patrice Chevallier
    Stéphane Vigouroux
    Pierre Peterlin
    Alice Garnier
    Marie-Thérèse Rubio
    Anne Huynh
    Noël Milpied
    Philippe Moreau
    Béatrice Gaugler
    Ibrahim Yakoub-Agha
    Mohamad Mohty
    Bone Marrow Transplantation, 2019, 54 : 1815 - 1826
  • [7] Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndrome
    Guillaume, Thierry
    Malard, Florent
    Magro, Leonardo
    Labopin, Myriam
    Tabrizi, Reza
    Borel, Cecile
    Chevallier, Patrice
    Vigouroux, Stephane
    Peterlin, Pierre
    Garnier, Alice
    Rubio, Marie-Therese
    Huynh, Anne
    Milpied, Noel
    Moreau, Philippe
    Gaugler, Beatrice
    Yakoub-Agha, Ibrahim
    Mohty, Mohamad
    BONE MARROW TRANSPLANTATION, 2019, 54 (11) : 1815 - 1826
  • [8] The outcome of elder patients with acute myeloid leukemia or high risk myelodysplastic syndrome treated with allogeneic hematopoietic stem cell transplantation
    Tsai, C. H.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S410 - S411
  • [9] Sequential Allogeneic Stem Cell Transplantation in High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome
    Zavrelova, Alzbeta
    Radocha, Jakub
    Lanska, Miriam
    Zak, Pavel
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S312 - S312
  • [10] Subcutaneous low-dose azacitidine as maintenance therapy following hematopoietic stem cell transplantation for acute myeloid leukemia and high-risk myelodysplastic syndrome-A propensity score matched analysis
    Americo, Andre Dias
    Silva, Cinthya Correa
    Kerbauy, Nassif
    Arcuri, Leonardo Javier
    Ribeiro, Andressa Alice Feitosa
    Hamerschlak, Nelson
    Santos, Fabio Pires Souza
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2024, 46 : S427 - S430
12345